AU Stock MarketDetailed Quotes
ACW Actinogen Medical Ltd
- 0.026
- 0.0000.00%
20min DelayNot Open Oct 15 15:25 AET
76.57MMarket Cap-4333P/E (Static)
0.026High0.026Low3.42MVolume0.026Open0.026Pre Close89.00KTurnover0.09952wk High0.15%Turnover Ratio2.95BShares0.01552wk Low-0.006EPS TTM57.79MFloat Cap1.777Historical HighLossP/E (Static)2.22BShs Float0.007Historical Low-0.006EPS LYR0.00%Amplitude--Dividend TTM3.71P/B1Lot Size--Div YieldTTM
About Actinogen Medical Ltd Company
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Company Profile
SymbolACW
Company NameActinogen Medical Ltd
Founded1999
MarketASX
Fiscal Year Ends06-30
Address109 Pitt Street Level 9, Suite 901
CitySydney
CountryAustralia
Zip Code2000
Phone+61 289647401
Websitehttps://www.actinogen.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Steven Gourlay
- Executive Director, Chief Executive Officer and Managing Director
- --
- Dana Hilt
- Chief Medical Officer
- --
- Jeff Carter
- Chief Financial Officer
- --
- Tamara Miller
- Senior Vice President - Product Development
- --
- Geoffrey E.D Brooke
- Non-Executive Chairman of the Board
- --
- George Morstyn
- Non-Executive Director
- --
- Nicki Vasquez
- Non-Executive Director
- --
- Malcolm John McComas
- Non-Executive Director
- --
- Peter Webse
- Company Secretary
- --
- Fujun Li
- Head of Manufacturing
- --
- Michael Roberts
- Investor Relations
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data